Epstein Files Search

EFTA01108062Set 9

2011-07-2715p3,795w

Range Reference Range Lab VAP (TM) CHOLESTEROL TEST DIRECTLY MEASURED LIPID ATT TOTAL LDL-C DIRECT 99 <130 mg/dL (Desirable range <100 mg/dL for CHD, Diabetes, or its equivalent) TOTAL ... fasted. TOTAL NON-1410L-C(LDL+VLDL) 161 H <160 mg/dL FOR SETTING LDL-C GOAL ATT LP(a) CHOLESTEROL 8.0 <10 mg/dL IDL-C 25 H <20 mg/dL REAL ... LDL-C 67 <100 mg/dL SUM TOTAL LDL-C 99 <130 mg/dL REAL-LDL SIZE PATTERN A A ( 1I 1 I Pattern B Pattern Pattern A Small, Dense LDL

https://www.justice.gov/epstein/files/DataSet%209/EFTA01108062.pdf

EFTA00304997Set 9

2018-01-055p1,467w

with CHD or diabetes and <70 mg/dL for diabetic patients with known heart disease. LDL-C is now calculated using the Martin-Hopkins calculation, which is a validated novel method ... providing better accuracy than the Friedewald equation in the estimation of LDL-C. Martin SS et al. JAMA. 2013;310(19): 2061-2068 (http://education.QuestDiagnostics.com/faq/FAQ164) CHOL/HDLC RATIO ... major ASCVD risk factor, treating to a non-HDL-C goal of <100 mg/dL (LDL-C of <70 mg/dL) is considered a therapeutic option. HS CRP 1.2 mg/L TP Average

https://www.justice.gov/epstein/files/DataSet%209/EFTA00304997.pdf

EFTA00317114Set 9

2018-08-035p1,375w

mg/dL for patients with CHD or diabetic patients with > or = 2 CHD risk factors. LDL-C is now calculated using the Martin-Hopkins calculation, which is a validated novel method ... providing better accuracy than the Friedewald equation in the estimation of LDL-C. Martin SS et al. JAMA. 2013;310(19): 2061-2068 (http://education.QuestDiagnostics.com/faq/FAQ164) CHOL/HDLC RATIO ... major ASCVD risk factor, treating to a non-HDL-C goal of <100 mg/dL (LDL-C of <70 mg/dL) is considered a therapeutic option. HS CRP 1.2 mg/L

https://www.justice.gov/epstein/files/DataSet%209/EFTA00317114.pdf

EFTA00304878Set 9

2018-08-305p1,343w

mg/dL for patients with CHD or diabetic patients with > or = 2 CHD risk factors. LDL-C is now calculated using the Martin-Hopkins calculation, which is a validated novel method ... providing better accuracy than the Friedewald equation in the estimation of LDL-C. Martin SS et al. JAMA. 2013;310(19): 2061-2068 (http://education.QuestDiagnostics.com/faq/FAQ164) CHOL/HDLC RATIO ... major ASCVD risk factor, treating to a non-HDL-C goal of <100 mg/dL (LDL-C of <70 mg/dL) is considered a therapeutic option. HS CRP 0.9 mg/L TP Lower

https://www.justice.gov/epstein/files/DataSet%209/EFTA00304878.pdf

EFTA00304870Set 9

2018-08-145p1,405w

mg/dL for patients with CHD or diabetic patients with > or = 2 CHD risk factors. LDL-C is now calculated using the Martin-Hopkins calculation, which is a validated novel method ... providing better accuracy than the Friedewald equation in the estimation of LDL-C. Martin SS et al. JAMA. 2013;310(19): 2061-2068 (http://education.QuestDiagnostics.com/faq/FAQ164) CHOL/HDLC RATIO ... major ASCVD risk factor, treating to a non-HDL-C goal of <100 mg/dL (LDL-C of <70 mg/dL) is considered a therapeutic option. HS CRP 1.3 mg/L TP Average

https://www.justice.gov/epstein/files/DataSet%209/EFTA00304870.pdf

EFTA00804474Set 9

2018-11-236p1,814w

mg/dL for patients with CHD or diabetic patients with > or = 2 CHD risk factors. LDL-C is now calculated using the Martin-Hopkins calculation, which is a validated novel method ... providing better accuracy than the Friedewald equation in the estimation of LDL-C. Martin SS et al. JAMA. 2013;310(19): 2061-2068 (http://education.QuestDiagnostics.com/faq/FAQ164) CHOL/HDLC RATIO ... major ASCVD risk factor, treating to a non-HDL-C goal of <100 mg/dL (LDL-C of <70 mg/dL) is considered a therapeutic option. HS CRP 1.1 mg/L

https://www.justice.gov/epstein/files/DataSet%209/EFTA00804474.pdf

EFTA00804470Set 9

2018-11-234p1,128w

mg/dL for patients with CHD or diabetic patients with > or = 2 CHD risk factors. LDL-C is now calculated using the Martin-Hopkins calculation, which is a validated novel method ... providing better accuracy than the Friedewald equation in the estimation of LDL-C. Martin SS et al. JAMA. 2013;310(19): 2061-2068 (http://education.QuestDiagnostics.com/faq/FAQ164) CHOL/HDLC RATIO ... major ASCVD risk factor, treating to a non-HDL-C goal of <100 mg/dL (LDL-C of <70 mg/dL) is considered a therapeutic option. COMPREHENSIVE METABOLIC MI PANEL GLUCOSE

https://www.justice.gov/epstein/files/DataSet%209/EFTA00804470.pdf

EFTA00804480Set 9

2018-12-172p567w

mg/dL for patients with CHD or diabetic patients with > or = 2 CHD risk factors. LDL-C is now calculated using the Martin-Hopkins calculation, which is a validated novel method ... providing better accuracy than the Friedewald equation in the estimation of LDL-C. Martin SS et al. JAMA. 2013;310(19): 2061-2068 (http://education.QuestDiagnostics.com/faq/FAQ164) CHOL/HDLC RATIO ... major ASCVD risk factor, treating to a non-HDL-C goal of <100 mg/dL (LDL-C of <70 mg/dL) is considered a therapeutic option. COMPREHENSIVE METABOLIC MI PANEL GLUCOSE

https://www.justice.gov/epstein/files/DataSet%209/EFTA00804480.pdf

EFTA00314225Set 9

2018-08-1415p4,271w

mg/dL for patients with CHD or diabetic patients with > or • 2 CHD risk factors. LDL-C is now calculated using the Martin-Hopkins calculation, which is a validated novel method ... providing better accuracy than the Friedewald equation in the estimation of LDL-C. Mar ' • • 2 1-20 a CHOL DL RATIO <5.0 Coale) MI NON HDL CHOLESTEROL ... major ASCVD risk factor, treating to a non-HDL-C goal of <100 mg/dL (LDL-C of <70 mg/c1L) is considered a therapeutic option. HS CRP 1.3 mg/li TP Average

https://www.justice.gov/epstein/files/DataSet%209/EFTA00314225.pdf

EFTA01108234Set 9

2013-09-2513p3,639w

Borderline-High 1300 - 1599 High 1600 - 2000 Very High > 2000 Lipids 01 LDL-C NOTES: mg/dL <100 01 LDL-C cannot be calculated because triglycerides are > 400 mg/dL. Optimal

https://www.justice.gov/epstein/files/DataSet%209/EFTA01108234.pdf

EFTA00304964Set 9

2013-09-2513p3,569w

Borderline-High 1300 - 1599 High 1600 - 2000 > 2000 Very High Lipids 01 LDL-C NOTES: mg/dL <100 01 LDL-C cannot be calculated because triglycerides are > 400 mg/dL. Optimal

https://www.justice.gov/epstein/files/DataSet%209/EFTA00304964.pdf

EFTA00287152Set 9

2016-09-149p2,942w

Borderline -High 1300 - 1599 High 1600 - 2000 Very High > 2000 Lipids 01 LDL-C mg/dL 0 - 99 Triglyceride result indicated is too high for an accurate LDL cholesterol estimation. Optimal ... optimal 100 - 129 Borderline 130 - 159 High 160 - 189 Very high 189 comment: 01 LDL-C is inaccurate if patient is non-fasting. HDL-C 27 Low mg/d1

https://www.justice.gov/epstein/files/DataSet%209/EFTA00287152.pdf